LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,623,777 | -3.9% | 43,788 | +15.6% | 0.00% | 0.0% |
| Q2 2023 | $2,730,571 | +15.0% | 37,872 | -47.6% | 0.00% | 0.0% |
| Q1 2023 | $2,374,914 | +16.5% | 72,295 | +136.9% | 0.00% | 0.0% |
| Q4 2022 | $2,038,135 | -21.6% | 30,511 | +1.1% | 0.00% | 0.0% |
| Q3 2022 | $2,600,000 | +9.5% | 30,189 | +13.4% | 0.00% | 0.0% |
| Q2 2022 | $2,375,000 | -10.3% | 26,618 | +13.1% | 0.00% | 0.0% |
| Q1 2022 | $2,647,000 | -20.6% | 23,528 | +9.0% | 0.00% | -50.0% |
| Q4 2021 | $3,334,000 | +48.2% | 21,583 | +33.6% | 0.00% | +100.0% |
| Q3 2021 | $2,250,000 | +13.5% | 16,153 | +6.8% | 0.00% | 0.0% |
| Q2 2021 | $1,983,000 | +27.9% | 15,118 | +48.7% | 0.00% | 0.0% |
| Q1 2021 | $1,550,000 | +15.7% | 10,168 | -24.5% | 0.00% | 0.0% |
| Q4 2020 | $1,340,000 | -39.1% | 13,476 | -41.6% | 0.00% | -50.0% |
| Q3 2020 | $2,200,000 | -3.3% | 23,083 | +13.5% | 0.00% | 0.0% |
| Q2 2020 | $2,275,000 | +55.0% | 20,338 | +0.7% | 0.00% | 0.0% |
| Q1 2020 | $1,468,000 | -13.1% | 20,189 | +24.6% | 0.00% | 0.0% |
| Q4 2019 | $1,689,000 | -15.7% | 16,197 | -19.6% | 0.00% | 0.0% |
| Q3 2019 | $2,004,000 | -15.7% | 20,134 | -3.3% | 0.00% | -33.3% |
| Q2 2019 | $2,377,000 | +6.5% | 20,826 | +17.3% | 0.00% | 0.0% |
| Q1 2019 | $2,232,000 | +17.0% | 17,752 | +26.3% | 0.00% | 0.0% |
| Q4 2018 | $1,907,000 | +59.4% | 14,050 | +143.1% | 0.00% | 0.0% |
| Q2 2018 | $1,196,000 | +23.6% | 5,779 | -2.0% | 0.00% | 0.0% |
| Q1 2018 | $968,000 | +5.0% | 5,899 | -12.4% | 0.00% | +50.0% |
| Q4 2017 | $922,000 | +1.9% | 6,732 | +1.2% | 0.00% | 0.0% |
| Q3 2017 | $905,000 | +27.6% | 6,655 | +13.8% | 0.00% | 0.0% |
| Q2 2017 | $709,000 | +16.2% | 5,847 | +1.5% | 0.00% | 0.0% |
| Q1 2017 | $610,000 | +10.7% | 5,762 | +5.9% | 0.00% | 0.0% |
| Q4 2016 | $551,000 | +12.0% | 5,443 | +12.9% | 0.00% | 0.0% |
| Q3 2016 | $492,000 | -18.8% | 4,823 | -5.1% | 0.00% | 0.0% |
| Q2 2016 | $606,000 | +17.4% | 5,084 | +5.5% | 0.00% | 0.0% |
| Q1 2016 | $516,000 | +19.2% | 4,818 | +20.6% | 0.00% | 0.0% |
| Q4 2015 | $433,000 | +50.9% | 3,996 | +19.2% | 0.00% | +100.0% |
| Q3 2015 | $287,000 | +39.3% | 3,353 | +63.9% | 0.00% | 0.0% |
| Q2 2015 | $206,000 | +795.7% | 2,046 | +373.6% | 0.00% | – |
| Q4 2014 | $23,000 | +21.1% | 432 | +7.2% | 0.00% | – |
| Q3 2014 | $19,000 | +58.3% | 403 | +111.0% | 0.00% | – |
| Q2 2014 | $12,000 | +71.4% | 191 | +87.3% | 0.00% | – |
| Q1 2014 | $7,000 | – | 102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |